FDA inspection
Zhongfu Pharmaceutical Co., Ltd.: FDA inspection ending May 24, 2024
FDA inspection 1241747 · Voluntary Action Indicated (VAI) · Weifang
Key facts
| Inspection ID | 1241747 |
|---|---|
| Firm | Zhongfu Pharmaceutical Co., Ltd. |
| FEI number | 3002808105 |
| Address | No. 2709 Yuwang North Street, Hanting District |
| City | Weifang |
| Country | China |
| Fiscal year | 2024 |
| Inspection end date | May 24, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data